XML 29 R39.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Restructuring and Contract Terminaiton Charges, Net (Tables)
 12 Months Ended
Dec. 29, 2019
Restructuring and Related Activities [Abstract]  
Restructuring and Related Costs [Table Text Block]

The following table summarizes the number of employees reduced, the initial restructuring or contract termination charges by operating segment, and the dates by which payments were substantially completed, or the expected dates by which payments will be substantially completed, for restructuring actions implemented during fiscal years 2019, 2018 and 2017 in continuing operations:
 
Workforce Reductions
 
Closure of Excess Facility
 
Total
 
(Expected) Date Payments Substantially Completed by
 
Headcount Reduction
 
Diagnostics
 
Discovery & Analytical Solutions
 
Diagnostics
 
Discovery & Analytical Solutions
 
 
Severance
 
Excess Facility
 
(In thousands, except headcount data)
 
 
 
 
Q4 2019 Plan

22
 
$
2,404

 
$
177

 
$
—

 
$
—

 
$
2,581

 
Q3 FY2020
 
—
Q3 2019 Plan

259
 
2,641

 
11,156

 
—

 
—

 
13,797

 
Q2 FY2020
 
—
Q2 2019 Plan

44
 
1,129

 
4,461

 
—

 
—

 
5,590

 
Q1 FY2020
 
—
Q1 2019 Plan

105
 
1,459

 
6,001

 
—

 
—

 
7,460

 
Q4 FY2019
 
—
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q4 2018 Plan

1
 
—

 
348

 
—

 
—

 
348

 
Q1 FY2019
 
—
Q3 2018 Plan

61
 
618

 
1,146

 
—

 
—

 
1,764

 
Q4 FY2019
 
—
Q1 2018 Plan

47
 
902

 
5,096

 
—

 
—

 
5,998

 
Q4 FY2019
 
—
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q4 2017 Plan

29
 
255

 
1,680

 
—

 
—

 
1,935

 
Q1 FY2019
 
—
Q3 2017 Plan

27
 
1,021

 
1,321

 
—

 
—

 
2,342

 
Q4 FY2018
 
—
Q1 2017 Plan

90
 
1,631

 
5,000

 
33

 
33

 
6,697

 
Q2 FY2018
 
Q2 FY2018
Schedule of Restructuring Reserve by Type of Cost [Table Text Block] The following table summarizes the Company's restructuring accrual balances and related activity by restructuring plan, as well as other accrual balances and related activity, during fiscal years 2019, 2018 and 2017 in continuing operations:

 
 
Balance at January 1, 2017
 
2017 Charges and Changes in Estimates, Net
 
2017 Amounts Paid
 
Balance at December 31, 2017
 
2018 Charges and Changes in Estimates, Net
 
2018 Amounts Paid
 
Balance at December 30, 2018
 
2019 Charges and Changes in Estimates, Net
 
2019 Amounts Paid
 
Balance at December 29, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Severance:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q4 2019 Plan
 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
2,581

 
$
(1,692
)
 
$
889

Q3 2019 Plan
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
13,797

 
(7,486
)
 
6,311

Q2 2019 Plan
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
5,590

 
(3,701
)
 
1,889

Q1 2019 Plan
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
7,483

 
(5,354
)
 
2,129

Q4 2018 Plan

 
—

 
—

 
—

 
—

 
348

 
—

 
348

 
3

 
(351
)
 
—

Q3 2018 Plan(1)

 
—

 
—

 
—

 
—

 
2,054

 
(639
)
 
1,415

 
(77
)
 
(1,314
)
 
24

Q1 2018 Plan(2)

 
—

 
—

 
—

 
—

 
5,998

 
(4,389
)
 
1,609

 
(1,069
)
 
(282
)
 
258

Q4 2017 Plan

 
—

 
1,935

 
(16
)
 
1,919

 
(381
)
 
(1,538
)
 
—

 
—

 
—

 
—

Q3 2017 Plan

 
—

 
2,342

 
(270
)
 
2,072

 
(1,204
)
 
(868
)
 
—

 
—

 
—

 
—

Q1 2017 Plan(3)

 
—

 
6,631

 
(4,133
)
 
2,498

 
(983
)
 
(1,232
)
 
283

 
(276
)
 
(7
)
 
—

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Facility:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q1 2017 Plan

 
—

 
66

 
(33
)
 
33

 
—

 
(33
)
 
—

 
—

 
—

 
—

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Previous Plans(4)
 
10,424

 
(1,568
)
 
(4,457
)
 
4,399

 
570

 
(2,581
)
 
2,388

 
117

 
(1,140
)
 
1,365

Restructuring
 
10,424

 
9,406

 
(8,909
)
 
10,921

 
6,402

 
(11,280
)
 
6,043

 
28,149

 
(21,327
)
 
12,865

Contract Termination
 
117

 
3,251

 
(320
)
 
3,048

 
4,742

 
(7,653
)
 
137

 
452

 
(401
)
 
188

Other Costs
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
827

 
—

 
827

Total Restructuring and Other Liabilities
 
$
10,541

 
$
12,657

 
$
(9,229
)
 
$
13,969

 
$
11,144

 
$
(18,933
)
 
$
6,180

 
$
29,428

 
$
(21,728
)
 
$
13,880

____________________________
(1) 
During fiscal year 2019, the Company recognized pre-tax restructuring reversals of $0.4 million in the Diagnostics segment related to lower than expected costs associated with workforce reductions and an additional expense of $0.3 million in the Discovery & Analytical Solutions segment for the Q3 2018 Plan.
(2) 
During fiscal year 2019, the Company recognized pre-tax restructuring reversals of $1.1 million in the Discovery & Analytical Solutions segment related to lower than expected costs associated with workforce reductions for the Q1 2018 Plan.
(3) 
During fiscal year 2019, the Company recognized pre-tax restructuring reversals of $0.3 million in the Discovery & Analytical Solutions segment related to lower than expected costs associated with workforce reductions for the Q1 2017 Plan.
(4) 
During fiscal year 2019, the Company recognized pre-tax restructuring expense of $0.1 million in the Discovery & Analytical Solutions segment related to higher than expected costs associated with workforce reductions for the Previous Plans.